The invention provides improved nucleic acid ligands with enhanced stability that inhibit coagulation and improved modulators of the nucleic acids to provide ideal modulators of coagulation. These improved nucleic acids and modulators are particularly useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass.

 
Web www.patentalert.com

< Non-neutralizing anti-aPC antibodies

> DISINFECTANT FORMULATION

> Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma

~ 00517